» Articles » PMID: 15285844

Inhibition of P-glycoprotein Function by Tea Catechins in KB-C2 Cells

Overview
Specialties Pharmacology
Pharmacy
Date 2004 Aug 3
PMID 15285844
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

We studied the effects of tea catechins, (-)-epicatechin (EC), (-)-epigallocatechin (EGC), (-)-epicatechin gallate (ECG), and (-)-epigallocatechin gallate (EGCG) on the P-glycoprotein (P-gp) function in multidrug-resistant P-gp over-expressing KB-C2 cells. EC did not have any effects on cellular accumulation of P-gp substrates, rhodamine-123 and daunorubicin, but the other catechins increased the accumulation in the order of EGC < ECG < EGCG. The effects of EGCG were larger than those of verapamil and quercetin. Since these catechins inhibited the efflux of P-gp substrates, the elevation of substrate accumulation seemed to be induced by the inhibition of the efflux transporter. The results showed that the inhibitory effects of the catechins did not depend on their total hydrophobicity, but significantly depended on their chemical structure. The presence of the galloyl moiety on the C-ring markedly increased the n-octanol/PBS partition coefficients of the catechins and their activity on P-gp. On the other hand, the presence of the trihydric pyrogallol group as the B-ring decreased the partition coefficients but increased the activity on P-gp, compared with the action of the corresponding catechins with a dihydric catechol B-ring.

Citing Articles

Structure-based discovery of novel P-glycoprotein inhibitors targeting the nucleotide binding domains.

Moesgaard L, Pedersen M, Nielsen C, Kongsted J Sci Rep. 2023; 13(1):21217.

PMID: 38040777 PMC: 10692163. DOI: 10.1038/s41598-023-48281-4.


Pentagalloyl Glucose-Targeted Inhibition of P-Glycoprotein and Re-Sensitization of Multidrug-Resistant Leukemic Cells (K562/ADR) to Doxorubicin: In Silico and Functional Studies.

Dechsupa N, Khamto N, Chawapun P, Siriphong S, Innuan P, Suwan A Pharmaceuticals (Basel). 2023; 16(9).

PMID: 37765000 PMC: 10535865. DOI: 10.3390/ph16091192.


Natural Products as a Tool to Modulate the Activity and Expression of Multidrug Resistance Proteins of Intestinal Barrier.

Martins-Gomes C, Silva A J Xenobiot. 2023; 13(2):172-192.

PMID: 37092502 PMC: 10123636. DOI: 10.3390/jox13020014.


Self-Assembled Daunorubicin/Epigallocatechin Gallate Nanocomplex for Synergistic Reversal of Chemoresistance in Leukemia.

Bae K, Lai F, Oruc B, Osato M, Chen Q, Kurisawa M Int J Mol Sci. 2023; 24(1).

PMID: 36613821 PMC: 9820275. DOI: 10.3390/ijms24010381.


Controversial Interactions of Tacrolimus with Dietary Supplements, Herbs and Food.

Miedziaszczyk M, Bajon A, Jakielska E, Primke M, Sikora J, Skowronska D Pharmaceutics. 2022; 14(10).

PMID: 36297591 PMC: 9611668. DOI: 10.3390/pharmaceutics14102154.